A Protocol for Engineering Collagen Type II Bioscaffolds to Support Stem Cell Chondrogenesis.

Zoi Piperigkou, Achilleas D Theocharis, Nikos K Karamanos

Abstract read

In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zoi PiperigkouBiochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece.

Achilleas D TheocharisBiochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece.

Nikos K KaramanosBiochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece. N.K.Karamanos@upatras.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix-based bioscaffolds are crucial tools to advance stem cell-based cartilage regeneration approaches. Collagen type II is one of the major extracellular matrix (ECM) components of hyaline cartilage, thus providing a favorable microenvironment for promoting chondrogenic differentiation. This chapter describes a standardized molecular biology protocol to develop collagen type II bioscaffolds in order to enhance the potential of mesenchymal stem cell (MSC) chondrogenic differentiation. The protocol outlines the preparation of collagen type II coating, including composition and crosslinking strategy. Functional assays, histological staining, gene expression analysis, and biochemical analysis confirm the formation of a cartilage-like matrix. Mimicking the cartilage microenvironment, collagen type II bioscaffolds serve as a biologically relevant platform for induced chondrogenesis, thus providing a matrix tool for MSC-based therapeutic approaches in regenerative medicine approaches.

Indexed as

ChondrogenesisCollagen Type IIMesenchymal Stem CellsTissue EngineeringTissue ScaffoldsAnimalsCell Culture TechniquesCell DifferentiationCells, CulturedExtracellular MatrixHumansCollagen Type IIBioscaffoldsChondrogenic differentiationCollagen IIExtracellular matrixMesenchymal stem cells

Identifiers

PMID42681161

DOI10.1007/s11033-023-08461-x

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.